Treatment of postpartum hemorrhage with blood products in a tertiary hospital: Outcomes and predictive factors associated with severe hemorrhage

Biblos-e Archivo/Manakin Repository

Show simple item record

dc.contributor.author Guasch, Emilia
dc.contributor.author Gilsanz, Fernando
dc.contributor.other UAM. Departamento de Cirugía es_ES
dc.contributor.other Instituto de Investigación Sanitaria Hospital Universitario de La Paz (IdiPAZ) es_ES
dc.date.accessioned 2017-07-24T17:19:44Z
dc.date.available 2017-07-24T17:19:44Z
dc.date.issued 2016-10-01
dc.identifier.citation Clinical and Applied Thrombosis/Hemostasis 22.7 (2016): 685-692 en_US
dc.identifier.issn 1076-0296 (print) es_ES
dc.identifier.issn 1938-2723 (online) es_ES
dc.identifier.uri http://hdl.handle.net/10486/679090
dc.description.abstract Postpartum hemorrhage (PPH) remains a leading cause of maternal mortality and morbidity worldwide. This retrospective observational study describes patient characteristics and hemostatic therapies administered to 352 parturients experiencing PPH and analyzes risk factors for developing severe PPH. During the study period, bleeding was controlled in all cases and 99.4% survived. The majority (98%) of patients received packed red blood cells. The most frequent hemostatic therapies administered were fibrinogen concentrate (56%), fresh frozen plasma (49%), and platelets (30%). A total of 124 (35%) women experienced severe PPH. Significant independent predictors for evolution to severe PPH were age, obstetric comorbidity, and plasma fibrinogen concentration. The latter was based on records from 267 (76%) patients. Plasma fibrinogen concentration before labor was the only modifiable prepartum risk factor independently associated with severe PPH, indicating that fibrinogen monitoring is warranted in these patients. en_US
dc.format.extent 8 pag. es_ES
dc.format.mimetype application/pdf en
dc.language.iso spa en
dc.publisher Sage Publications, Inc en_US
dc.relation.ispartof Clinical and Applied Thrombosis/Hemostasis en_US
dc.rights © The Author(s) 2015 es_ES
dc.subject.other Bleeding en_US
dc.subject.other Blood coagulation factors en_US
dc.subject.other Gynecology and obstetrics en_US
dc.title Treatment of postpartum hemorrhage with blood products in a tertiary hospital: Outcomes and predictive factors associated with severe hemorrhage en_US
dc.type article en
dc.subject.eciencia Medicina es_ES
dc.relation.publisherversion https://doi.org/10.1177/1076029615573303 es_ES
dc.identifier.doi 10.1177/1076029615573303 es_ES
dc.identifier.publicationfirstpage 685 es_ES
dc.identifier.publicationissue 7 es_ES
dc.identifier.publicationlastpage 692 es_ES
dc.identifier.publicationvolume 22 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion en
dc.rights.cc Reconocimiento – NoComercial es_ES
dc.rights.accessRights openAccess en
dc.authorUAM Gilsanz Rodríguez, Fernando (260228)


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record